Topic: EPILEPSY

REPORT FROM AAN 2024 – TUESDAY, APRIL 16

April 16, 2024  

Elevated sNfL a possible biomarker of recent seizure in epilepsy

April 5, 2024  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Phase III trials in neurology – 2018 in review

January 24, 2019  

Record number of FDA drug approvals in 2018

January 9, 2019  

Marijuana in neurology – POTential benefit?

March 23, 2018  

Seizure count an inaccurate endpoint in epilepsy trials

August 31, 2017  

AAN 2017 DAILY REPORT

April 27, 2017  

Teratogenic potential of antiepileptic drugs: need for research, patient education

May 25, 2016  

Managing epilepsy: are patients satisfied?

July 23, 2014